Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...